Silver Book Fact

New cancer treatments account for large percent of life expectancy gains

Fact image

Sun, E, D Lakdawalla, C Ryes, D Goldman, T Philipson, et al. The Determinants of Recent Gains in Cancer Survival: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database. J Clin Oncolo. 2008; 27(15S). http://meeting.ascopubs.org/cgi/content/short/26/15_suppl/6616

Reference

Title
The Determinants of Recent Gains in Cancer Survival: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database
Publication
J Clin Oncolo
Publication Date
2008
Authors
Sun, E, D Lakdawalla, C Ryes, D Goldman, T Philipson, et al.
Volume & Issue
Volume 27, Issue 15S
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Use of an epidermal growth factor inhibitor in the treatment of metastatic colon cancer patients without the KRAS gene mutation saw survival rates of 15.6 months, compared to 5.6 months…  
  • 750 cancer-fighting medicines are currently in development.  
  • Medicines in Development for Cancer  
  • A one percent reduction in cancer-related deaths in the U.S. would be worth an estimated $500 billion to society from increased quality of life and increased productivity from longer lives.  
  • A drug for testicular cancer that cost an estimated $56 million to develop led to a sharp increase in survival rate and an annual return of $166 million in treatment…